15-Oct-2026 - Fintel UBS upgrades Regeneron Pharmaceuticals to buy from neutral Fintel reports that on October 15, 2026, UBS upgraded their outlook for Regeneron Pharmaceuticals (BMV:REGN) from Neutral to Buy. Regeneron Pharmaceuticals, Inc. is an American biotechnology company ...
2-Oct-2026 - Fintel Argus Research upgrades Regeneron Pharmaceuticals to buy from hold Fintel reports that on October 1, 2026, Argus Research upgraded their outlook for Regeneron Pharmaceuticals (BMV:REGN) from Hold to Buy. Regeneron Pharmaceuticals, Inc. is an American biotechnology ...
24-Sep-2026 - Yahoo Finance Regeneron (REGN) Stock Still Looks Undervalued After A 40% Run Regeneron Pharmaceuticals has delivered a strong share price run over the past year, which puts a spotlight on whether the current US$801.82 level is still grounded in what the business earns today.
15-Oct-2026 - Fintel UBS upgrades Regeneron Pharmaceuticals to buy from neutral Fintel reports that on October 15, 2026, UBS upgraded their outlook for Regeneron Pharmaceuticals (BMV:REGN) from Neutral to Buy. Regeneron Pharmaceuticals, Inc. is an American biotechnology company ...
2-Oct-2026 - Fintel Argus Research upgrades Regeneron Pharmaceuticals to buy from hold Fintel reports that on October 1, 2026, Argus Research upgraded their outlook for Regeneron Pharmaceuticals (BMV:REGN) from Hold to Buy. Regeneron Pharmaceuticals, Inc. is an American biotechnology ...
24-Sep-2026 - Yahoo Finance Regeneron (REGN) Stock Still Looks Undervalued After A 40% Run Regeneron Pharmaceuticals has delivered a strong share price run over the past year, which puts a spotlight on whether the current US$801.82 level is still grounded in what the business earns today.
